Home infusion therapy refers to administering biological drugs in a patient’s home, either by the patient themselves, their family, nurse, or others. Home infusion services include patient training and education, administration, care coordination, pharmacy services, and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications from the physician’s office. Through agencies, nursing services for home care are also provided.
The senior population is the largest consumer of home infusion therapy. As the global population is aging, this population possesses a high risk and susceptibility of this population group to developing chronic conditions that require infusion therapy. Growing demand for home healthcare by the disabled patient group will additionally widen the base for home infusion therapy. Augmenting the use of home infusion therapy also results in a reduction in hospital readmission and in-patient stays, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infections, thus presenting a potential market penetration opportunity.
The global home infusion therapy market is segmented on the following basis:
- Pumps for Infusion
- Sets IV
- Intravenous Cannulas
- Type of Therapy
- Hydration Treatment
- Pharmaceutical Specialtes
- Consumables and Other Items
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Key players identified for the healthcare analytical testing market include but are not limited to:
Fresenius Kabi, Baxter, Inc., B. Braun Melsungen AG, Smiths Medical, CareFusion Corporation, Caesarea Medical Electronics, and several others
This report offers the following:
- An overview of the global markets for home infusion therapy
- Market trends assessment for the period 2014-2022, including historical data for 2014 and 2015, as well as projections through 2022, with respective CAGRs from 2016 to 2022.
- Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
- market competition scrutiny tools such as market share analysis, attractive investment propositions, and Porter’s Five Forces model
- Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
- A general overview of the industry structure
- Company profiles highlight key information about the major players operating in the home infusion therapy market.